CCL11 and myeloid sarcoma: Further studies are needed do define the details of the regulatory pathways involved in this diseases protection, but this study indicates that modulation of Ccl11 expression and downstream signaling through CCR3 could provide efficient strategies for immuno-modulation in MS and other inflammatory diseases.